Michael Bigham - Oct 25, 2022 Form 4 Insider Report for Paratek Pharmaceuticals, Inc. (PRTK)

Role
Exec. Chairman of the Board, Director
Signature
/s/ William M. Haskell, Attorney-in-Fact for Michael Bigham
Stock symbol
PRTK
Transactions as of
Oct 25, 2022
Transactions value $
$0
Form type
4
Date filed
10/27/2022, 07:00 PM
Previous filing
Aug 10, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Award $0 +30K +2.48% $0.00 1.24M Oct 25, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units ("PRSUs") granted on July 31, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 25, 2022.